- Home
- VNDA vs FLYX Comparison
VNDA vs FLYX Comparison
Compare VNDA & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FLYX
- Stock Information
- Founded
- VNDA 2002
- FLYX 2015
- Country
- VNDA United States
- FLYX United States
- Employees
- VNDA N/A
- FLYX N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FLYX Blank Checks
- Sector
- VNDA Health Care
- FLYX Finance
- Exchange
- VNDA Nasdaq
- FLYX Nasdaq
- Market Cap
- VNDA 282.8M
- FLYX 264.1M
- IPO Year
- VNDA 2006
- FLYX N/A
- Fundamental
- Price
- VNDA $4.98
- FLYX $3.05
- Analyst Decision
- VNDA Strong Buy
- FLYX
- Analyst Count
- VNDA 2
- FLYX 0
- Target Price
- VNDA $16.50
- FLYX N/A
- AVG Volume (30 Days)
- VNDA 751.6K
- FLYX 35.3K
- Earning Date
- VNDA 05-07-2025
- FLYX 01-01-0001
- Dividend Yield
- VNDA N/A
- FLYX N/A
- EPS Growth
- VNDA N/A
- FLYX N/A
- EPS
- VNDA N/A
- FLYX N/A
- Revenue
- VNDA $198,772,000.00
- FLYX $311,873,000.00
- Revenue This Year
- VNDA $14.36
- FLYX $4.63
- Revenue Next Year
- VNDA $44.53
- FLYX $33.97
- P/E Ratio
- VNDA N/A
- FLYX N/A
- Revenue Growth
- VNDA 3.18
- FLYX N/A
- 52 Week Low
- VNDA $3.71
- FLYX $1.79
- 52 Week High
- VNDA $6.75
- FLYX $18.99
- Technical
- Relative Strength Index (RSI)
- VNDA 58.23
- FLYX 44.17
- Support Level
- VNDA $4.84
- FLYX $3.00
- Resistance Level
- VNDA $5.10
- FLYX $3.35
- Average True Range (ATR)
- VNDA 0.24
- FLYX 0.35
- MACD
- VNDA 0.02
- FLYX -0.04
- Stochastic Oscillator
- VNDA 76.40
- FLYX 18.99
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.